Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery.
Katopodi T, Petanidis S, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Dagher M, Varsamis N, Theodorou V, Mystakidou CM, Katsios NI, Farmakis K, Kosmidis C.
Katopodi T, et al. Among authors: eskitzis p.
Pharmaceutics. 2023 Oct 13;15(10):2458. doi: 10.3390/pharmaceutics15102458.
Pharmaceutics. 2023.
PMID: 37896218
Free PMC article.
Review.